| | A Tanzanian doctor working in Uganda who contracted Ebola has died, the first health worker killed by the disease in the latest outbreak in the country, Uganda's health minister said on Saturday. | | | France will tighten measures to contain bird flu after a resurgence of the virus that swept through poultry flocks last winter, said the agriculture ministry, adding that the nationwide alert level on bird flu had been raised to 'moderate' from 'low'. | | | Around two-thirds of adults in the United States do not plan to get updated COVID-19 booster shots soon, according to a survey conducted by the Kaiser Family Foundation (KFF), a health policy nonprofit organization. | | | Amylyx Pharmaceuticals Inc on Friday set the list price of its newly approved drug to treat amyotrophic lateral sclerosis (ALS) at about $158,000 per year in the United States, a discount to its most recently approved competitor. | | | Intercept Pharmaceuticals Inc said on Friday its treatment for patients with advanced liver scarring due to non-alcoholic steatohepatitis (NASH) failed to meet the main goal of a late-stage study, sending its shares down as much as 21%. | | | Cholera cases have surged this year, especially in places of poverty and conflict, with outbreaks reported in 26 countries and fatality rates rising sharply, a World Health Organization official said on Friday. | | | Italians will no longer have to wear face masks on public transport, the health ministry said late on Thursday, in the latest easing of rules against the coronavirus pandemic. | | | Clear evidence this week that Eisai and Biogen's drug lecanemab slows cognitive decline in early stage dementia has galvanized efforts among Alzheimer's researchers toward a tantalizing goal - preventing dementia even before symptoms start. | | | Patriarch Kirill of Moscow, the head of the Russian Orthodox Church, has tested positive for COVID-19, the Church's press service said on Friday. | | | For most of China's 1.4 billion people, regular COVID-19 tests have become a way of life. Siyuan Zhuji is trying to turn them into a work of art. | | | | |